Update: 05.05.2025
Last week: 16 week 2025 (14.04.2025 - 20.04.2025)
Last full month: March 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 757 | -3.7% | 12.7% | 0.1 | 21 923 781 | -3.6% | 9.6% | 0.1 | -4.1% |
| MoM | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| YTD | 147 394 | 26.8% | 12.8% | 1.8 | 317 900 938 | 22.1% | 9.4% | 0 | 8.9% |
| MAT | 452 595 | 24.8% | 12.9% | 3.1 | 896 574 386 | 20.0% | 9.3% | 1 | -5.0% |
| BRAINMAX | |||||||||
| WoW | 2 880 | 1.7% | 100.0% | 0 | 10 199 216 | 4.6% | 100.0% | 0 | 1.7% |
| MoM | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| YTD | 39 760 | 134.3% | 100.0% | 0 | 137 365 301 | 127.6% | 100.0% | 0 | 134.3% |
| MAT | 105 457 | 98.9% | 100.0% | 0 | 363 740 702 | 96.1% | 100.0% | 0 | 98.9% |
| GOLDLINE PLUS | |||||||||
| WoW | 17 610 | 4.0% | 45.7% | 0.9 | 56 449 989 | 4.8% | 37.4% | 0.6 | 2.0% |
| MoM | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| YTD | 261 360 | -3.8% | 45.9% | 1.5 | 845 893 087 | -2.4% | 37.6% | 1.3 | -6.9% |
| MAT | 818 743 | -6.1% | 45.9% | 0.4 | 2 582 342 859 | -5.9% | 37.6% | -1.2 | -6.8% |
| MIGRENIUM | |||||||||
| WoW | 8 230 | 3.7% | 0.3% | 0 | 2 906 699 | 3.2% | 0.5% | 0 | 1.4% |
| MoM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| YTD | 132 726 | -33.6% | 0.4% | -0.2 | 46 451 542 | -20.1% | 0.5% | -0.2 | 4.2% |
| MAT | 500 785 | -22.4% | 0.4% | -0.1 | 169 996 440 | 16.9% | 0.6% | 0 | 0.1% |
| MODELAX-N | |||||||||
| WoW | 26 640 | 0.1% | 18.7% | 0 | 14 243 250 | 0.5% | 13.7% | 0 | 0.0% |
| MoM | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| YTD | 480 547 | -6.3% | 20.5% | -3.3 | 250 059 370 | 18.3% | 14.6% | -0.3 | 8.7% |
| MAT | 1 431 434 | 5.7% | 20.7% | 0.1 | 697 973 204 | 42.1% | 14.1% | 2.2 | 5.0% |
| REDUXIN | |||||||||
| WoW | 12 093 | 1.2% | 31.4% | -0.3 | 66 055 281 | 3.0% | 43.7% | 0 | 2.0% |
| MoM | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| YTD | 181 302 | -10.6% | 31.8% | -1.3 | 988 308 257 | -10.5% | 43.9% | -2.3 | -6.9% |
| MAT | 573 994 | -7.4% | 32.2% | -0.2 | 3 048 048 789 | -0.9% | 44.4% | 0.8 | -6.8% |
| REDUXIN FORTE | |||||||||
| WoW | 3 796 | 1.4% | 9.9% | -0.1 | 17 138 038 | 0.2% | 11.3% | -0.3 | 2.0% |
| MoM | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| YTD | 56 096 | 5.7% | 9.8% | 1.2 | 253 397 904 | 9.2% | 11.3% | 1.5 | -6.9% |
| MAT | 170 401 | 1.1% | 9.6% | 0.8 | 743 105 180 | 6.6% | 10.8% | 1 | -6.8% |
| SALVISAR | |||||||||
| WoW | 12 465 | -10.9% | 1.7% | -0.2 | 6 345 249 | -10.2% | 1.6% | -0.2 | 0.1% |
| MoM | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
| YTD | 216 789 | 33.8% | 1.9% | 0.5 | 105 574 472 | 69.5% | 1.8% | 0.6 | -5.0% |
| MAT | 626 485 | 28.7% | 1.6% | 0.5 | 284 221 452 | 67.1% | 1.5% | 0.5 | -7.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 147 394 | 26.8% | 12.8% | 1.8 | 317 900 938 | 22.1% | 9.4% | 0 | 8.9% |
| BRAINMAX | 39 760 | 134.3% | 100.0% | 0 | 137 365 301 | 127.6% | 100.0% | 0 | 134.3% |
| GOLDLINE PLUS | 261 360 | -3.8% | 45.9% | 1.5 | 845 893 087 | -2.4% | 37.6% | 1.3 | -6.9% |
| MIGRENIUM | 132 726 | -33.6% | 0.4% | -0.2 | 46 451 542 | -20.1% | 0.5% | -0.2 | 4.2% |
| MODELAX-N | 480 547 | -6.3% | 20.5% | -3.3 | 250 059 370 | 18.3% | 14.6% | -0.3 | 8.7% |
| REDUXIN CAPS | 181 302 | -10.6% | 31.8% | -1.3 | 988 308 257 | -10.5% | 43.9% | -2.3 | -6.9% |
| REDUXIN FORTE | 56 096 | 5.7% | 9.8% | 1.2 | 253 397 904 | 9.2% | 11.3% | 1.5 | -6.9% |
| SALVISAR | 216 789 | 33.8% | 1.9% | 0.5 | 105 574 472 | 69.5% | 1.8% | 0.6 | -5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 452 595 | 24.8% | 12.9% | 3.1 | 896 574 386 | 20.0% | 9.3% | 1 | -5.0% |
| BRAINMAX | 105 457 | 98.9% | 100.0% | 0 | 363 740 702 | 96.1% | 100.0% | 0 | 98.9% |
| GOLDLINE PLUS | 818 743 | -6.1% | 45.9% | 0.4 | 2 582 342 859 | -5.9% | 37.6% | -1.2 | -6.8% |
| MIGRENIUM | 500 785 | -22.4% | 0.4% | -0.1 | 169 996 440 | 16.9% | 0.6% | 0 | 0.1% |
| MODELAX-N | 1 431 434 | 5.7% | 20.7% | 0.1 | 697 973 204 | 42.1% | 14.1% | 2.2 | 5.0% |
| REDUXIN CAPS | 573 994 | -7.4% | 32.2% | -0.2 | 3 048 048 789 | -0.9% | 44.4% | 0.8 | -6.8% |
| REDUXIN FORTE | 170 401 | 1.1% | 9.6% | 0.8 | 743 105 180 | 6.6% | 10.8% | 1 | -6.8% |
| SALVISAR | 626 485 | 28.7% | 1.6% | 0.5 | 284 221 452 | 67.1% | 1.5% | 0.5 | -7.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 757 | -3.7% | 12.7% | 0.1 | 21 923 781 | -3.6% | 9.6% | 0.1 | -4.1% |
| BRAINMAX | 2 880 | 1.7% | 100.0% | 0 | 10 199 216 | 4.6% | 100.0% | 0 | 1.7% |
| GOLDLINE PLUS | 17 610 | 4.0% | 45.7% | 0.9 | 56 449 989 | 4.8% | 37.4% | 0.6 | 2.0% |
| MIGRENIUM | 8 230 | 3.7% | 0.3% | 0 | 2 906 699 | 3.2% | 0.5% | 0 | 1.4% |
| MODELAX-N | 26 640 | 0.1% | 18.7% | 0 | 14 243 250 | 0.5% | 13.7% | 0 | 0.0% |
| REDUXIN CAPS | 12 093 | 1.2% | 31.4% | -0.3 | 66 055 281 | 3.0% | 43.7% | 0 | 2.0% |
| REDUXIN FORTE | 3 796 | 1.4% | 9.9% | -0.1 | 17 138 038 | 0.2% | 11.3% | -0.3 | 2.0% |
| SALVISAR | 12 465 | -10.9% | 1.7% | -0.2 | 6 345 249 | -10.2% | 1.6% | -0.2 | 0.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| BRAINMAX | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| GOLDLINE PLUS | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| MIGRENIUM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| MODELAX-N | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| REDUXIN CAPS | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| REDUXIN FORTE | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| SALVISAR | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs